Racial, Ethnic Disparities Seen in Management of NSTEMI
Blacks, Hispanics less likely than Whites to undergo coronary angiography, PCI for acute non-ST-segment elevation myocardial infarction
Myocardial Infarction
Stopping RAS Inhibitors After AKI Ups Risk for Adverse Events
Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators.
Hypertension Ups Odds of Omicron-Variant COVID-19 Hospitalization
Observational study findings highlight a “persistent and marked” association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.
Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
USPSTF Issues Recommendations on Aspirin Use to Prevent Cardiovascular Disease
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
Risk for Acute MI Not Increased With 2-Dose HepB-CpG Vaccine
Noninferiority study shows no increased risk for acute MI with two-dose HepB-CpG vaccine versus three-dose HepB-alum vaccine
USPSTF Updates Guidance on Statins for Primary Prevention of CVD
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
High-Dose IV Iron Reduces Myocardial Infarction in Hemodialysis
Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis.
New Drugs Approved in 2021
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
Polypharmacy May Increase Risks for Kidney Failure, Cardiovascular Events
Avoiding unnecessary medications in CKD might reduce the risks for adverse outcomes, investigators suggested.
